UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by RMR Wealth Builders

RMR Wealth Builders raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,682 shares of the healthcare conglomerate’s stock after purchasing an additional 370 shares during the period. RMR Wealth Builders’ holdings in UnitedHealth Group were worth $1,412,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. CGC Financial Services LLC lifted its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA lifted its holdings in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares in the last quarter. Finally, Annapolis Financial Services LLC grew its stake in shares of UnitedHealth Group by 38.6% in the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock worth $40,000 after acquiring an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $503.21 on Thursday. The firm has a market cap of $462.99 billion, a PE ratio of 30.76, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. The company’s 50 day simple moving average is $481.45 and its 200-day simple moving average is $511.98. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.26 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Piper Sandler boosted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Morgan Stanley cut their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research report on Thursday, April 4th. Finally, Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.